This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P170002S012 |
Classification Name | None |
Applicant | |
PMA | P170002 |
Supplement | S012 |
Supplement Number | Date | Supplement Type |
---|---|---|
P170002 | Original Filing | |
S025 | 2022-12-27 | 30-day Notice |
S024 | ||
S023 | ||
S022 | ||
S021 | 2022-03-17 | Real-time Process |
S020 | 2022-01-31 | 30-day Notice |
S019 | 2021-07-26 | Real-time Process |
S018 | 2021-07-16 | 30-day Notice |
S017 | 2021-04-26 | 30-day Notice |
S016 | 2021-04-02 | 30-day Notice |
S015 | 2021-03-29 | 30-day Notice |
S014 | 2021-03-16 | Special (immediate Track) |
S013 | 2021-02-17 | 30-day Notice |
S012 | ||
S011 | ||
S010 | 2020-07-20 | 135 Review Track For 30-day Notice |
S009 | 2020-02-14 | 30-day Notice |
S008 | 2020-02-13 | 30-day Notice |
S007 | 2019-11-13 | 30-day Notice |
S006 | ||
S005 | 2019-06-18 | Real-time Process |
S004 | 2019-03-12 | 135 Review Track For 30-day Notice |
S003 | 2019-03-12 | 30-day Notice |
S002 | 2019-02-21 | 30-day Notice |
S001 |